Double-hit Signature with <i>TP53</i> Abnormalities Predicts Poor Survival in Patients with Germinal Center Type Diffuse Large B-cell Lymphoma Treated with R-CHOP

Joo Y. Song(City of Hope), Dennis D. Weisenburger(University of Nebraska Medical Center)
Clinical Cancer Research
January 7, 2021
Cited by 42


Related Papers